Financhill
Back

Biolase Stock Predictions

Biolase Stock Forecast

  • Is Biolase Stock Undervalued?
    The current Biolase [BIOLQ] share price is $0.0075. The Score for BIOLQ is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • BIOLQ is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Biolase Stock Go Up Next Year?

Data Unavailable

Biolase Stock Rating

Data Unavailable

Biolase Stock Price History

Is BIOLQ stock going to rise?

  • The current trend is relatively stagnant and BIOLQ is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
OTCM
Country:
United States
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
biolase.com

52-Week Data

52-Week High:
1.2700
52-Week Low:
0.0040

Prediction Charts

Market Cap:
274.5K
Price in USD:
0.0075
Volume:
28.5K
Beta:
1.6462

Technical Analysis

SMA50:
0.0076
SMA100:
0.0302
SMA200:
0.0828
52-Wk Change:
-99.34%

Stock Predictions

  • Is Biolase stock public?
    Yes, Biolase is a publicly traded company.
  • What is the Biolase stock quote today?
    The Biolase stock price is 0.0075 USD today.
  • How to buy Biolase stock online?
    You can buy Biolase shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 0.0090 0.0082 0.0090 0.0050
Dec-4 0.0089 0.0090 0.0090 0.0060
Dec-5 0.0089 0.0090 0.0090 0.0060
Dec-6 0.0061 0.0070 0.0099 0.0061
Dec-9 0.0065 0.0072 0.0099 0.0064
Dec-10 0.0095 0.0090 0.0095 0.0072
Dec-11 0.0072 0.0080 0.0081 0.0072
Dec-12 0.0072 0.0080 0.0095 0.0070
Dec-13 0.0094 0.0080 0.0094 0.0080
Dec-16 0.0080 0.0082 0.0090 0.0071
Dec-17 0.0071 0.0133 0.0133 0.0071
Dec-18 0.0130 0.0150 0.0153 0.0071
Dec-19 0.0150 0.0074 0.0150 0.0072
Dec-20 0.0074 0.0075 0.0080 0.0074

Biolase Earnings

Data Unavailable

Biolase Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.40 per share, and an increase next year of $0.24 per share.

* Biolase stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.